Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cytotoxic Drug”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01690325
What this trial is testing

Imaging for Response Assessment of Neoadjuvant Chemotherapy in Primary Breast Cancer (GALADON)

Who this might be right for
Breast Cancer
Women's Cancer Study Group GmbH 21
Testing effectiveness (Phase 2)Study completedNCT03396952
What this trial is testing

Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma

Who this might be right for
Stage III Cutaneous MelanomaStage IIIA Cutaneous MelanomaStage IIIB Cutaneous Melanoma+2 more
University of California, San Francisco 27
Testing effectiveness (Phase 2)Study completedNCT00194714
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IV HLA-A2 and HER2 Positive Breast or Ovarian Cancer Receiving Trastuzumab

Who this might be right for
HER2/Neu PositiveHLA-A2 Positive Cells PresentStage IV Breast Cancer+1 more
University of Washington 22
Early research (Phase 1)Study completedNCT00000904
What this trial is testing

Safety and Effectiveness of Anti-HIV Vaccines in HIV-Negative Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableLooking for participantsNCT06844136
What this trial is testing

ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients

Who this might be right for
Ovarian Cancer
Pierian Biosciences 100
Early research (Phase 1)Ended earlyNCT02231853
What this trial is testing

Phase I/II Trial of Early Infusion of Rapidly-generated Multivirus Specific T Cells (MVST) to Prevent Post Transplant Viral Infections

Who this might be right for
Chronic Lymphocytic LeukemiaCML (Chronic Myelogenous Leukemia)MDS (Myelodysplastic Syndrome)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 12
Testing effectiveness (Phase 2)UnknownNCT00986557
What this trial is testing

T-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Donor Stem Cell Transplant

Who this might be right for
Graft Versus Host DiseaseNonneoplastic Condition
University Hospital Birmingham 78
Testing effectiveness (Phase 2)WithdrawnNCT03988582
What this trial is testing

Safety and Effectiveness of EBV-specific Cytotoxic T Cells for the Treatment for EBV Lymphomas or Other EBV-associated Malignancies

Who this might be right for
EBV LymphomasEBV-associated Malignancies
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00062868
What this trial is testing

LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma

Who this might be right for
Hodgkin DiseaseNon Hodgkin LymphomaLymphoepithelioma+1 more
Baylor College of Medicine 74
Large-scale testing (Phase 3)Active Not RecruitingNCT05732805
What this trial is testing

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

Who this might be right for
MelanomaMelanoma (Skin)Melanoma Stage III+4 more
Biocad 270
Testing effectiveness (Phase 2)Looking for participantsNCT03266627
What this trial is testing

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Who this might be right for
AdenovirusPrimary Immune Deficiency Disorder
New York Medical College 20
Early research (Phase 1)Looking for participantsNCT07012044
What this trial is testing

Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Post Cytotoxic TherapyRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
National Cancer Institute (NCI) 47
Large-scale testing (Phase 3)Study completedNCT00033475
What this trial is testing

Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation

Who this might be right for
Lymphoproliferative Disorder
University of Edinburgh 50
Large-scale testing (Phase 3)Looking for participantsNCT06763328
What this trial is testing

Metformin for the Treatment of Insulin Resistance in Women With Stage I-III Breast Cancer Completing Chemotherapy

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
City of Hope Medical Center 80
Early research (Phase 1)Ended earlyNCT01067066
What this trial is testing

A Phase I Study of TPI 287 - Temozolomide Combination in Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 21
Early research (Phase 1)Study completedNCT00006495
What this trial is testing

Immune Responses in HIV-Positive Patients Receiving an Anti-HIV Drug Combination When Given the HIV Vaccines Remune and vCP1452

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Early research (Phase 1)Study completedNCT01588769
What this trial is testing

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma Multiforme
CytoVac A/S 23
Early research (Phase 1)Looking for participantsNCT01555892
What this trial is testing

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Who this might be right for
Hodgkin's DiseaseNon-Hodgkin's LymphomaLymphoproliferative Disease+1 more
Baylor College of Medicine 136
Large-scale testing (Phase 3)Ended earlyNCT04729387
What this trial is testing

Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected

Who this might be right for
Ovarian Cancer
Novartis Pharmaceuticals 358
Testing effectiveness (Phase 2)Ended earlyNCT01935947
What this trial is testing

Azacitidine and Entinostat Before Chemotherapy in Treating Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage IIIA Non-Small Cell Lung CancerStage IIIB Non-Small Cell Lung Cancer+1 more
National Cancer Institute (NCI) 17
Next Page